Table 1. MDS characteristics and response to IST3, 26.
Variable | Impact | ||
---|---|---|---|
Favorable | No effect | Unfavorable | |
Disease status | RA, RAEB, IPSS low/int-1 | RARS, Secondary MDS Advanced MDS | |
HLA type | DR15 | ||
Age | <60 years | ||
Sex | female | ||
Duration of transfusion dependence | short | ||
Karyotype | trisomy 8 | other karyotype | |
IST regimen | ATG+CSA | ||
Other | PNH Hypoplastic marrow |